<?xml version='1.0' encoding='utf-8'?>
<document id="22459452"><sentence text="Effect of aceclofenac on pharmacokinetic of phenytoin."><entity charOffset="10-21" id="DDI-PubMed.22459452.s1.e0" text="aceclofenac" /><entity charOffset="44-53" id="DDI-PubMed.22459452.s1.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.22459452.s1.e0" e2="DDI-PubMed.22459452.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s1.e0" e2="DDI-PubMed.22459452.s1.e1" /></sentence><sentence text="Aceclofenac is presently most commonly prescribed analgesic for chronic pain and inflammatory conditions"><entity charOffset="0-11" id="DDI-PubMed.22459452.s2.e0" text="Aceclofenac" /></sentence><sentence text=" In clinical practice, phenytoin and aceclofenac are used in a chronic condition of generalized seizure with concomitant chronic pain"><entity charOffset="23-32" id="DDI-PubMed.22459452.s3.e0" text="phenytoin" /><entity charOffset="37-48" id="DDI-PubMed.22459452.s3.e1" text="aceclofenac" /><pair ddi="false" e1="DDI-PubMed.22459452.s3.e0" e2="DDI-PubMed.22459452.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s3.e0" e2="DDI-PubMed.22459452.s3.e1" /></sentence><sentence text=" Hence there are chances of drug-drug interaction because modulations of isoenzymes involved in metabolism of phenytoin and aceclofenac are CYP2C9/10 and CYP2C19"><entity charOffset="110-119" id="DDI-PubMed.22459452.s4.e0" text="phenytoin" /><entity charOffset="124-135" id="DDI-PubMed.22459452.s4.e1" text="aceclofenac" /><pair ddi="false" e1="DDI-PubMed.22459452.s4.e0" e2="DDI-PubMed.22459452.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s4.e0" e2="DDI-PubMed.22459452.s4.e1" /></sentence><sentence text=" It is important to maintain the therapeutic level of phenytoin in plasma for effective control of seizure"><entity charOffset="54-63" id="DDI-PubMed.22459452.s5.e0" text="phenytoin" /></sentence><sentence text=" So, the aim of the study was to determine the effect of aceclofenac on the pharmacokinetics of phenytoin in rabbits"><entity charOffset="57-68" id="DDI-PubMed.22459452.s6.e0" text="aceclofenac" /><entity charOffset="96-105" id="DDI-PubMed.22459452.s6.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.22459452.s6.e0" e2="DDI-PubMed.22459452.s6.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s6.e0" e2="DDI-PubMed.22459452.s6.e1" /></sentence><sentence text=" In a parallel design study, phenytoin 30 mg/kg/day per oral was given daily for seven days"><entity charOffset="29-38" id="DDI-PubMed.22459452.s7.e0" text="phenytoin" /></sentence><sentence text=" On day 7, blood samples were taken at various time intervals between 0-24 hours" /><sentence text=" In aceclofenac group, phenytoin was administered for seven days as above"><entity charOffset="4-15" id="DDI-PubMed.22459452.s9.e0" text="aceclofenac" /><entity charOffset="23-32" id="DDI-PubMed.22459452.s9.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.22459452.s9.e0" e2="DDI-PubMed.22459452.s9.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s9.e0" e2="DDI-PubMed.22459452.s9.e1" /></sentence><sentence text=" On day 8, aceclofenac 14 mg/kg along with phenytoin 30 mg/kg/day was administered and blood samples drawn as above"><entity charOffset="43-52" id="DDI-PubMed.22459452.s10.e0" text="phenytoin" /></sentence><sentence text=" Plasma phenytoin levels were assayed by HPLC and pharmacokinetic parameters were calculated" /><sentence text=" In aceclofenac group, there was decrease in tÂ½el than phenytoin group significant changes were observed in the pharmacokinetic parameters in aceclofenac treated group"><entity charOffset="4-15" id="DDI-PubMed.22459452.s12.e0" text="aceclofenac" /><entity charOffset="55-64" id="DDI-PubMed.22459452.s12.e1" text="phenytoin" /><entity charOffset="142-153" id="DDI-PubMed.22459452.s12.e2" text="aceclofenac" /><pair ddi="false" e1="DDI-PubMed.22459452.s12.e0" e2="DDI-PubMed.22459452.s12.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s12.e0" e2="DDI-PubMed.22459452.s12.e1" /><pair ddi="false" e1="DDI-PubMed.22459452.s12.e0" e2="DDI-PubMed.22459452.s12.e2" /><pair ddi="false" e1="DDI-PubMed.22459452.s12.e1" e2="DDI-PubMed.22459452.s12.e1" /><pair ddi="false" e1="DDI-PubMed.22459452.s12.e1" e2="DDI-PubMed.22459452.s12.e2" /></sentence><sentence text=" These results suggest that aceclofenac alter the pharmacokinetics of phenytoin"><entity charOffset="28-39" id="DDI-PubMed.22459452.s13.e0" text="aceclofenac" /><entity charOffset="70-79" id="DDI-PubMed.22459452.s13.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.22459452.s13.e0" e2="DDI-PubMed.22459452.s13.e0" /><pair ddi="false" e1="DDI-PubMed.22459452.s13.e0" e2="DDI-PubMed.22459452.s13.e1" /></sentence><sentence text=" Confirmation of these results in human studies will warrant changes in phenytoin dose or frequency when aceclofenac is co-administered with it"><entity charOffset="105-116" id="DDI-PubMed.22459452.s14.e0" text="aceclofenac" /></sentence><sentence text="" /></document>